LABCORP HOLDINGS INC.

For the period ended Mar 31, 2026. Filed May 4, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 4, 2026

LH$371.83+1.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Commonly Used Abbreviations

The abbreviations listed below may be commonly used in this report.
AMCA	American Medical Collection Agency
AR Facility	accounts receivable securitization facility
ASU	Accounting Standards Update
BLS	Biopharma Laboratory Services
Board	board of directors of Labcorp Holdings Inc.
CODM	chief operating decision maker
Common Stock	common stock, par value $0.10 per share
CRO	contract research organization
DCP	deferred compensation plan
Dx	Diagnostics Laboratories
ED	Early Development Research Laboratories
EPS	earnings per share
FASB	Financial Accounting Standards Board
Fortrea	Fortrea Holdings Inc.
GAAP	U.S. generally accepted accounting principles
LCAH	Laboratory Corporation of America Holdings
MCO	managed care organization
N/A	not applicable
OBBBA	One Big Beautiful Bill Act
OCR	U.S. Office of Civil Rights
Parkview	Parkview Health System, Inc.
PSC	patient service center
S&P	Standard & Poor’s
SEC	U.S. Securities and Exchange Commission
SG&A	selling, general, and administrative expenses
SOFR	secured overnight financing rate
Spin-off	June 2023 spin-off of Fortrea
SPV	bankruptcy-remote special purpose vehicle
2026 Term Loan	term loan credit agreement entered on March 20, 2026
TSA	transition services agreement with Fortrea
U.K.	United Kingdom
U.S.	United States of America
USD	U.S. Dollar

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.